These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23557056)

  • 1. Are the new policies on hyperandrogenism in elite female athletes really out of bounds? Response to "out of bounds? A critique of the new policies on hyperandrogenism in elite female athletes".
    Bermon S; Ritzén M; Hirschberg AL; Murray TH
    Am J Bioeth; 2013; 13(5):63-5. PubMed ID: 23557056
    [No Abstract]   [Full Text] [Related]  

  • 2. Reexamining rationales of "fairness": an athlete and insider's perspective on the new policies on hyperandrogenism in elite female athletes.
    Viloria HP; Martínez-Patino MJ
    Am J Bioeth; 2012; 12(7):17-9. PubMed ID: 22694024
    [No Abstract]   [Full Text] [Related]  

  • 3. Getting a leg up on the competition: the importance of osteology in elite athletics.
    Sutherland MB; Langer B; Wassersug R
    Am J Bioeth; 2012; 12(7):25-7. PubMed ID: 22694028
    [No Abstract]   [Full Text] [Related]  

  • 4. New standards, same refrain: the IAAF's regulations on hyperandrogenism.
    Schultz J
    Am J Bioeth; 2012; 12(7):32-3. PubMed ID: 22694031
    [No Abstract]   [Full Text] [Related]  

  • 5. The Harrison Bergeron olympics.
    Karkazis K; Jordan-Young R
    Am J Bioeth; 2013; 13(5):66-9. PubMed ID: 23557057
    [No Abstract]   [Full Text] [Related]  

  • 6. The complexities of sport, gender, and drug testing.
    Sailors PR; Teetzel SJ; Weaving C
    Am J Bioeth; 2012; 12(7):23-5. PubMed ID: 22694027
    [No Abstract]   [Full Text] [Related]  

  • 7. Sport is arbitrary, and that's ok.
    O'Connor D; Dasgupta I
    Am J Bioeth; 2012; 12(7):30-1. PubMed ID: 22694030
    [No Abstract]   [Full Text] [Related]  

  • 8. Excellence, deviance, and gender: lessons from the XYY episode.
    Shani R; Barilan YM
    Am J Bioeth; 2012; 12(7):27-30. PubMed ID: 22694029
    [No Abstract]   [Full Text] [Related]  

  • 9. Gender transports: privileging the "natural" in gender testing debates for intersex and transgender athletes.
    Wahlert L; Fiester A
    Am J Bioeth; 2012; 12(7):19-21. PubMed ID: 22694025
    [No Abstract]   [Full Text] [Related]  

  • 10. Sport, sex segregation, and sex testing: critical reflections on this unjust marriage.
    Dworkin SL; Cooky C
    Am J Bioeth; 2012; 12(7):21-3. PubMed ID: 22694026
    [No Abstract]   [Full Text] [Related]  

  • 11. Out of bounds? A critique of the new policies on hyperandrogenism in elite female athletes.
    Karkazis K; Jordan-Young R; Davis G; Camporesi S
    Am J Bioeth; 2012; 12(7):3-16. PubMed ID: 22694023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperandrogenism and intersex controversies in women's olympics.
    Xavier NA; McGill JB
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3902-7. PubMed ID: 22990091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large divergence in testosterone concentrations between men and women: Frame of reference for elite athletes in sex-specific competition in sports, a narrative review.
    Clark RV; Wald JA; Swerdloff RS; Wang C; Wu FCW; Bowers LD; Matsumoto AM
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):15-22. PubMed ID: 30136295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new policy on hyperandrogenism in elite female athletes is not about "sex testing".
    Sánchez FJ; Martínez-Patiño MJ; Vilain E
    J Sex Res; 2013; 50(2):112-5. PubMed ID: 23320653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperandrogenism among elite adolescent female athletes.
    Eliakim A; Marom N; Galitskaya L; Nemet D
    J Pediatr Endocrinol Metab; 2010 Aug; 23(8):755-8. PubMed ID: 21073117
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular diagnosis of 5α-reductase deficiency in 4 elite young female athletes through hormonal screening for hyperandrogenism.
    Fénichel P; Paris F; Philibert P; Hiéronimus S; Gaspari L; Kurzenne JY; Chevallier P; Bermon S; Chevalier N; Sultan C
    J Clin Endocrinol Metab; 2013 Jun; 98(6):E1055-9. PubMed ID: 23633205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hurdling over sex? Sport, science, and equity.
    Ha NQ; Dworkin SL; Martínez-Patiño MJ; Rogol AD; Rosario V; Sánchez FJ; Wrynn A; Vilain E
    Arch Sex Behav; 2014 Aug; 43(6):1035-42. PubMed ID: 25085349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of sex in elite sport.
    Photopoulos J
    Nature; 2021 Apr; 592(7852):S12-S15. PubMed ID: 33790458
    [No Abstract]   [Full Text] [Related]  

  • 19. Sex, health, and athletes.
    Jordan-Young RM; Sönksen PH; Karkazis K
    BMJ; 2014 Apr; 348():g2926. PubMed ID: 24776640
    [No Abstract]   [Full Text] [Related]  

  • 20. Women with hyperandrogenism in elite sports: scientific and ethical rationales for regulating.
    Bermon S; Vilain E; Fénichel P; Ritzén M
    J Clin Endocrinol Metab; 2015 Mar; 100(3):828-30. PubMed ID: 25587809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.